Global Current Research Status and Future Hotspots in Osteoporotic Fracture Based on Bibliometric Assessment and Visualization Techniques

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2024 Jul 12

PMID 38994286

Authors

Yu-Ming Wang

Ping Yi

Affiliations

Soon will be listed here.

Abstract

Background: In the past decade, the evolution of themes in the field of osteoporotic fractures has changed from epidemiology and prediction of long-term morbidity, risk assessment of osteoporotic fractures, and zoledronic acid and denosumab in the treatment of osteoporosis to treatment guidelines for osteoporosis and the side effects caused by anti-osteoporotic drugs.

Aim: To understand the trends and hotspots in osteoporotic fracture research.

Methods: Original articles were retrieved between January 1, 2010, and December 31, 2019, from the Web of Science Core Collection database. CiteSpace software facilitated the analysis and visualization of scientific productivity and emerging trends.

Results: Nine studies were identified using bibliometric indices, including citation, centrality, and sigma value, which might indicate a growing trend. Through clustering, we identified six major hot subtopics. Using burst analysis, top-5 references with the strongest bursting strength after 2017 were identified, indicating a future hotspot in this field.

Conclusion: Current hot subtopics in osteoporotic fracture research include atypical femoral fractures, androgen deprivation therapy, denosumab discontinuation, hip fractures, trabecular bone score (TBS), and bone phenotype. Management and prevention of secondary fractures in patients with osteoporotic fractures, TBSs, and long-term administration strategy for zoledronic acid are expected to become research hotspots.

References

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

Silva B, Broy S, Boutroy S, Schousboe J, Shepherd J, Leslie W . Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. J Clin Densitom. 2015; 18(3):309-30. DOI: 10.1016/j.jocd.2015.06.008. View

Black D, Delmas P, Eastell R, Reid I, Boonen S, Cauley J . Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007; 356(18):1809-22. DOI: 10.1056/NEJMoa067312. View

Ominsky M, Stouch B, Schroeder J, Pyrah I, Stolina M, Smith S . Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys. Bone. 2011; 49(2):162-73. DOI: 10.1016/j.bone.2011.04.001. View

Cummings S, San Martin J, McClung M, Siris E, Eastell R, Reid I . Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009; 361(8):756-65. DOI: 10.1056/NEJMoa0809493. View

Miller P, Bolognese M, Lewiecki E, McClung M, Ding B, Austin M . Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone. 2008; 43(2):222-229. DOI: 10.1016/j.bone.2008.04.007. View

Burge R, Dawson-Hughes B, Solomon D, Wong J, King A, Tosteson A . Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2006; 22(3):465-75. DOI: 10.1359/jbmr.061113. View

Si L, Winzenberg T, Jiang Q, Chen M, Palmer A . Projection of osteoporosis-related fractures and costs in China: 2010-2050. Osteoporos Int. 2015; 26(7):1929-37. DOI: 10.1007/s00198-015-3093-2. View

Chen J, Lin P, Tsai Y, Yang Y, Kang H . Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy. Cells. 2019; 8(11). PMC: 6912771. DOI: 10.3390/cells8111318. View

10.

Kanis J, Johnell O, Oden A, Johansson H, McCloskey E . FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19(4):385-97. PMC: 2267485. DOI: 10.1007/s00198-007-0543-5. View

11.

Shane E, Burr D, Abrahamsen B, Adler R, Brown T, Cheung A . Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2013; 29(1):1-23. DOI: 10.1002/jbmr.1998. View

12.

Ganda K, Puech M, Chen J, Speerin R, Bleasel J, Center J . Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2012; 24(2):393-406. DOI: 10.1007/s00198-012-2090-y. View

13.

Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

14.

Shin W, Moon N, Jang J, Seo H, Suh K . A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation. Bone. 2019; 128:115033. DOI: 10.1016/j.bone.2019.08.006. View

15.

Kanis J, Burlet N, Cooper C, Delmas P, Reginster J, Borgstrom F . European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008; 19(4):399-428. PMC: 2613968. DOI: 10.1007/s00198-008-0560-z. View

16.

Amir E, Tannock I . Prostate cancer: Androgen deprivation therapy and bone loss. Nat Rev Urol. 2009; 6(12):642-4. DOI: 10.1038/nrurol.2009.218. View

17.

Jiang G, Huang C, Zhang X, Lv X, Wang Y, Yu T . Wnt signaling in liver disease: emerging trends from a bibliometric perspective. PeerJ. 2019; 7:e7073. PMC: 6590390. DOI: 10.7717/peerj.7073. View

18.

Zhang H, Weng H, Li M, Zhang J . Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment. Osteoporos Int. 2019; 30(11):2349-2354. DOI: 10.1007/s00198-019-05131-2. View

19.

Adler R, Fuleihan G, Bauer D, Camacho P, Clarke B, Clines G . Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2016; 31(10):1910. DOI: 10.1002/jbmr.2918. View

20.

Synnestvedt M, Chen C, Holmes J . Visual exploration of landmarks and trends in the medical informatics literature. AMIA Annu Symp Proc. 2006; :1129. PMC: 1560559. View